Header Logo

Connection

STEVEN BOEYNAEMS to Oligonucleotides, Antisense

Back to Details
This is a "connection" page, showing publications STEVEN BOEYNAEMS has written about Oligonucleotides, Antisense.
STEVEN BOEYNAEMS
Connection Strength
0.047
Oligonucleotides, Antisense
  1. Genome-wide CRISPR screen reveals v-ATPase as a drug target to lower levels of ALS protein ataxin-2. Cell Rep. 2022 10 25; 41(4):111508.
    View in: PubMed
    Score: 0.047
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.